Truist Securities boosted the price target for BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from $125 to $140. Truist Securities analyst Robyn Karnauskas maintained a Buy rating. BioMarin Pharmaceutical shares fell 3.6% to close at $88.93 on Thursday.
Companies Reporting Before The Bell
• Teck Resources (NYSE:TECK) is expected to report quarterly earnings at $1.36 per share on revenue of $3.11 billion.
RBC Capital Markets analyst Tom Callaghan initiated coverage on FirstService Corp (NASDAQ:FSV) with Outperform Rating with a price target of $165. The…
FirstService Residential assumes leadership position in the Greater Toronto Metropolitan Area, the top urban development market in North America
TORONTO, April 4, 2023 /CNW/ - FirstService
FirstService (NASDAQ:FSV) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement.
Analysts estimate that FirstService will report an earnings per share (EPS) of $1.20.